Switzerland· 69069005
Vildagliptin Metformin NOBEL 50 mg/1000 mg, Filmtabletten
A metformin und vildagliptin product containing vildagliptinum, metformini hydrochloridum, registered in Switzerland by NOBEL Pharma Schweiz AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Metformin und vildagliptin is registered in 11 of 19 countries.
Countries holding a registration under ATC A10BD08 (metformin und vildagliptin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Metformin und vildagliptin · ATC A10BD08
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- vildagliptinum, metformini hydrochloridum
- Manufacturer
- NOBEL Pharma Schweiz AG
- Country
- Switzerland (CH)
- ATC code
- A10BD08
- ATC class
- Metformin und Vildagliptin
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680690690052Blist 60 StkCHF 38.45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin und vildagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin und vildagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under A10BD08
Metformin und vildagliptin, as other registers publish it.
- PolandAlikval DuoEgis Pharmaceuticals PLC
- PolandAlikval DuoEgis Pharmaceuticals PLC
- CzechiaALIKVAL DUOEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVAL DUOEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVAL DUOEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVAL DUOEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVAL DUOEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVAL DUOEgis Pharmaceuticals PLC, Budapešť
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e27695d1-8a82-464e-bb22-c7aee8d8a53c GET /v1/drugs/e27695d1-8a82-464e-bb22-c7aee8d8a53c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "vildagliptinum 50 mg + metformini hydrochloridum 1000 mg",
"valid_from": "2024-12-01",
"limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, welche mit den bisherigen oralen Therapien nur ungenügend eingestellt werden können oder diese nicht vertragen.<br>\\n- Als Dreifachkombination mit einem Sulfonylharnstoff als Zusatz zu Diät und körperlicher Bewegung, wenn mit Metformin und einem Sulfonylharnstoff allein keine ausreichende Kontrolle der Glykämie erreicht werden kann.<br>\\n- In Kombination mit Insulin zur Verbesserung der Blutzuckerkontrolle, wenn mit Diät, körperlicher Bewegung sowie durch die Behandlung mit einer stabilen Dosis Insulin und Metformin keine ausreichende Kontrolle der Glykämie erreicht werden kann.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"21871.01\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-12-01\"}]",
"galenic_form": "Filmtabl 50/1000 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2024-12-01",
"self_retention_pct": 10
}See everything about metformin und vildagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.